Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04716010 · ClinicalTrials.gov registry record · NA
Developing and Evaluating Product Messaging
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 4,160
- Enrollment target
NCT04716010: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT04716010 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4,160 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04716010, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,160 participants
- Enrollment target
Study Summary
Purpose: To assess the impact of taxes, warnings, and a combination of taxes and warnings on US adults' decisions to purchase products that contain red meat in an online grocery store. Procedures (methods): Participants will be recruited from Prime Panels (an online panel research company). Following online consent, participants will be assigned to one of four trial arms: 1) Control (no warning and no tax), 2) Warnings (all products that contain red meat have a health warning and environmental warning), 3) Tax (30% tax on products that contain red meat), and 4) Combined warning and tax (all products that contain red meat will have the two warnings and a 30% tax). Then, participant will enter an online grocery store reflecting their assigned arm. The participant will be instructed to complete a shopping task in the online grocery store. After completing the shopping task, participants will be redirected to an online survey and answer a series of questions about the shopping task, labels (excluding tax and control groups), and taxes (excluding warning and control groups). Questions will also include standard demographic and health related variables.
Primary Outcome
The number of products in a participant's shopping basket that contain red meat.
Interventions
- OTHER Control
- OTHER Warning Labels
- OTHER Tax
- OTHER Combined Warning Labels and Tax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,160 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2021-10-28 |
| Phase | NA |
What the finished NCT04716010 record still lists
NCT04716010 is an interventional study that assigns participants to a tested intervention. Its 4,160 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher).
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT04716010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04716010 about?
NCT04716010 is a clinical study titled "Developing and Evaluating Product Messaging". Purpose: To assess the impact of taxes, warnings, and a combination of taxes and warnings on US adults' decisions to purchase products that contain red meat in an online grocery store. Procedures (methods): Participants will be recruited from Prime Panels (an online panel research company). Followi...
What is the current status of trial NCT04716010?
This trial is currently completed. It is a NA study. The enrollment target is 4,160 participants. The study started on 2021-10-18. Estimated completion is 2021-10-28.
What interventions are being tested in trial NCT04716010?
The interventions under investigation include: Control (OTHER), Warning Labels (OTHER), Tax (OTHER), Combined Warning Labels and Tax (OTHER).
Who is sponsoring clinical trial NCT04716010?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04716010's enrollment target sits among peer trials
4,160 32nd of 2000 higher than 1,969 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI